Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL2000262	盐酸伊立替康氟脲苷脂质体注射液	floxuridine;irinotecan hydrochloride	Injection	Chemical Drugs(2.2;2.3)	New Drug Application	2020-06-12	南京绿叶制药有限公司	Nanjing Sike Medicine Industry Co Ltd	In Review	2020-06-11	view
CXHL1600292	盐酸伊立替康脂质体注射液	irinotecan hydrochloride	Injection	Chemical Drugs(2.2)	New Drug Application	2017-04-05	南京绿叶制药有限公司	Nanjing Sike Medicine Industry Co Ltd	Certificate Issued	2017-11-30	view
CXHL2000306	盐酸伊立替康脂质体注射液	irinotecan hydrochloride	Injection	Chemical Drugs(2.2)	New Drug Application	2020-06-29	南京绿叶制药有限公司	Nanjing Sike Medicine Industry Co Ltd	In Review	2020-06-28	view
CXHL2100170	盐酸罗哌卡因脂质体混悬注射液	ropivacaine hydrochloride	Injection	Chemical Drugs(2.2)	New Drug Application	2021-03-05	南京绿叶制药有限公司	Nanjing Sike Medicine Industry Co Ltd	In Review	2021-03-05	view